The polyol pathway - A culprit in diabetic neuropathy?

Neuroscience Research Communications

Volumn 21, Issue 1, 1997, Pages 33-40

  Oates, Peter J ^a  

^a PFIZER INC   (United States)

Author keywords

Aldose reductase; ARI; Diabetes mellitus; Neuropathy; Polyol pathway; Review

Indexed keywords

ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; GLUCOSE; POLYOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; BIOCHEMISTRY; DIABETES MELLITUS; DIABETIC NEUROPATHY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; NERVE FUNCTION; NONHUMAN; REVIEW;

EID: 0030747855     PISSN: 08936609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6769(199707)21:1<33::AID-NRC205>3.0.CO;2-H     Document Type: Review

References (83)

1. Greene, D. A. et al. (1988) Diabetes Metab. Rev. 4, 201.
2. Thomas, P. K. and Tomlinson, D. R., (1993) In: Peripheral Neuropathy, 2. P. K. Thomas, et al., (eds). W. B. Saunders Co., Philadelphia, p. 1219.
3. Dyck, P. J. and Giannini, C. (1996) J. Neuropathol. & Exp. Neurol. 55, 1181.
4. Low, P. A. and Suarez, G. A. (1995) Baillieres Clin. Neurol. 4, 401.
5. Watkins, P. J. (1992) Diabetol. 35, 2.
6. Vinik, A. I. et al. (1995) Diab. Care 18, 1037.
7. Thomas, P. K. (1986) Drugs 32 (Suppl. 2), 36.
8. Ziegler, D. et al. (1992) J. Diabet. Complications 6, 49.
9. Tesfaye, S. et al. (1996) Diabetol. 39, 1377.
10. Dyck, P. J. et al. (1993) Neurol. 43, 817.
11. Boulton, A. J. (1994) Can. J. Neurol. Sci. 21, S18.
12. Bell, D. S. (1991) Postgrad. Med. 89, 237.
13. The DCCT Research Group. (1995) Ann. Intern. Med. 122, 561.
14. Calcutt, N. A. and Dunn, J. (1997) Anesthiol. Clin. N. Amer. In press.
15. Nicolucci, A. et al. (1996) Diab. Care 19, 927.
16. Vinik, A. I. and Richardson, D. W. (1997) South. Med. J. 90, 268.
17. Engelstad, J. K. et al. (1997) J. Neuropathol. & Exp. Neurol. 56, 255.
18. Low, P. et al. (1989) Int. Rev. Neurobiol. 31, 355.
19. Cameron, N. E. et al. (1994) Diabetol. 37, 651.
20. Yagihashi, S. (1995) Diabetes Metab. Rev. 11, 193.
21. 20a Ward, J. D. (1995) Clin. Invest. Med., 18, 267.
22. Greene, D. A. et al. (1993) Diabetes Metab. Rev. 9, 189.
23. Tomlinson, D. R. et al. (1996) Phil. Trans. Roy. Soc. (Lond.) 351, 455.
24. Dyck, P. J. (1996) Lancet 348, 1044.
25. Vinik, A. I. et al. (1995) Diab. Rev. 3, 139.
26. Partanen, J. et al. (1995) N. Engl. J. Med. 333, 89.
27. de Neeling, J. N. D. et al. (1996) Diabet. Med. 13, 960.
28. The DCCT Research Group. (1993) N. Engl. J. Med. 329, 977.
29. Reichard, P. et al. (1993) N. Engl. J. Med. 329, 304.
30. Amthor, K. F. et al. (1994) Diabetol. 37, 579.
31. Kinoshita, J. H. and Nishimura, C. (1988) Diabetes Metab. Rev. 4, 323.
32. Brownlee, M. et al. (1988) Diabetes Metab. Rev. 4, 437.
33. Lee, T. S. et al. (1989) Proc. Natl. Acad. Sci. USA 86, 5141.
34. Kim, J. et al. (1991) Diabetes 40, 558.
35. Baynes, J. W. (1991) Diabetes 40, 405.
36. Crabbe, M. J. et al. (1996) Nature Struct. Biol. 3, 659.
37. Cameron, N. E. and Cotter, M. A. (1993) Diabet. Med. 10, 593.
38. Hers, H. G. (1956) Biochim. Biophys. Acta 22, 202.
39. Gabbay, K. H. et al. (1966) Science 151, 209.
40. Kador, P. F. (1988) Medicinal Res. Rev. 8, 325.
41. Burg, M. B. (1996) Kid. Int. 49, 1684.
42. Stevens, M. J. et al. (1993) Diabetol. 36, 608.
43. Williamson, J. R. et al. (1993) Diabetes 42, 801.
44. Cheng, H. M. (1988) Metab. Pediatr. Syst. Ophthalmol. 11, 152.
45. Van Dam, P. S. et al. (1995) Diabetes Metab. Rev. 11, 181.
46. Stevens, M. J. et al. (1994) J. Clin. Invest. 94, 853.
47. Vander Jagt, D. L. et al. (1992) J. Biol. Chem. 267, 4364.
48. Sima, A. A. et al. (1988) N. Engl. J. Med. 319, 548.
49. Tomlinson, D. R. etal. (1992) Pharmacol. Therapeut. 54, 151.
50. Sarges, R. and Gates, P. J. (1993) Prog. Drug Res. 40, 99.
51. Massen, E. A. and Boulton, A. J. (1990) Drugs 39, 190.
52. Hotta, N. et al. (1996) J. Diabet. Complications 10, 168.
53. Foppiano, M. and Lombardo, G. (1997) Lancet 349, 399.
54. Tomlinson, D. R. et al. (1994) Trends Pharm. Sci. 15, 293.
55. Hotta, N. (1995) Biomed. Pharmacother. 49, 232.
56. Mylari, B. L. et al. (1991) J. Med. Chem. 34, 108.
57. Inskeep, P. B. et al. (1994) J. Clin. Pharmacol. 34, 760.
58. Arezzo, J. C. et al. (1996) Diabetes 45 (Suppl. 2), 276A.
59. Terashima, H. et al. (1984) J. Pharmacol. Exp. Ther. 229, 226.
60. Kanamaru, M. et al. (1989) Eur. J. Clin. Pharmacol. 36 (Suppl.), A315.
61. Greene, D. et al. (1996) Diabetes 45 (Suppl. 2), 5A.
62. Hohman, T. et al. (1996) Diabetes 45 (Suppl. 2), 5A.
63. Sima, A. A. and Greene, D. A. (1993) Diabet. Med. 10 (Suppl 2), 33S.
64. Mizisin, A. P. et al. (1997) Diabetes 46, 647.
65. Calcutt, N. A. et al. (1995) Eur. J. Pharmacol. 285, 189.
66. Tomlinson, D. R. (1992) Diabetes Metab. Rev. 8, 67.
67. van Gerven, J. M. A. and Tjon-A-Tsien, A. M. L. (1995) Drugs & Aging 6, 9.
68. Müller-Felber, W. et al. (1993) Diabetes 42, 1482.
69. Solders, G. et al. (1992) Diabetes 41, 946.
70. Kennedy, W. R. et al. (1990) N. Engl. J. Med. 322, 1031.
71. Landgraf, R. (1996) Diabetol. 39, 1415.
72. Ziegler, D. et al. (1992) Diabet. Med. 9, 622.
73. Veves, A. et al. (1991) Diabet. Med. 8, 917.
74. Sima, A. A. (1992) J. Diabet. Complications 6, 64.
75. Greene, D. (1987) In: Diabetic Neuropathy, P. Dyck et al., (eds.) W.B. Saunders Co., Philadelphia. p. 177.
76. Pfeifer, M. A. and Schumer, M. P. (1995) Diabetes 44, 1355.
77. Judzewitsch, R. G. et al. (1983) N. Engl. J. Med. 308, 119.
78. Engerman, R. L. et al. (1994) Diabetol. 37, 141.
79. The Sorbinil Neuropathy Study Group. (1993) Neurol. 43, 1141.
80. Nicolucci, A. et al. (1996) Diabet. Med. 13, 1017.
81. Santiago, J. V. et al. (1993) J. Diabet. Complications 7, 170.
82. Nicolucci, A. et al. (1996) Diab. Care 19, 1091.
83. Stribling, D. (1990) Exp. Eye Res. 50, 621.